Fresenius SE & Co KGaA (FRA:FRE) Given a €59.40 Price Target at JPMorgan Chase & Co.

Share on StockTwits

JPMorgan Chase & Co. set a €59.40 ($69.07) price target on Fresenius SE & Co KGaA (FRA:FRE) in a research report sent to investors on Tuesday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

Other equities analysts have also recently issued research reports about the stock. Barclays set a €51.00 ($59.30) target price on shares of Fresenius SE & Co KGaA and gave the stock a neutral rating in a research report on Friday, October 18th. DZ Bank restated a buy rating on shares of Fresenius SE & Co KGaA in a research report on Monday, November 4th. HSBC set a €53.00 ($61.63) target price on shares of Fresenius SE & Co KGaA and gave the stock a neutral rating in a research report on Thursday, November 21st. Nord/LB set a €58.00 ($67.44) target price on shares of Fresenius SE & Co KGaA and gave the stock a buy rating in a research report on Tuesday, October 29th. Finally, Independent Research set a €51.00 ($59.30) target price on shares of Fresenius SE & Co KGaA and gave the stock a neutral rating in a research report on Wednesday, October 30th. Eight analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average price target of €55.37 ($64.38).

Shares of FRE opened at €48.27 ($56.13) on Tuesday. The company has a 50-day moving average of €49.86 and a two-hundred day moving average of €46.34. Fresenius SE & Co KGaA has a 12-month low of €60.16 ($69.95) and a 12-month high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Featured Article: Most Volatile Stocks

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.